Conavi Medical Corp.
CNVIF
Pozycja w akcjach
#32774
Conavi Medical Corp. is a medical technology firm that specializes in... Conavi Medical Corp. is a medical technology firm that specializes in developing, manufacturing, and commercializing advanced imaging solutions. These innovations are specifically designed to provide guidance during minimally invasive cardiovascular procedures. A notable product is the Novasight Hybrid System, which uniquely combines intravascular ultrasound (IVUS) and optical coherence tomography (OCT) into a single platform. This enables clinicians to obtain simultaneous and precisely co-registered images of the coronary arteries. Conavi Medical Corp. is headquartered in Toronto, Canada.
Cena akcji
$0.1027
Kapitalizacja rynkowa
$8.77M
Zmiana (1 dzień)
5.79%
Zmiana (1 rok)
-87.44%
Kraj
CA
Handel Conavi Medical Corp. (CNVIF)
Kategoria
Healthcare
EPS dla Conavi Medical Corp. (CNVIF)
EPS na dzień June 2024 TTM: $-0.04
Według najnowszych raportów finansowych i ceny akcji firmy Conavi Medical Corp., obecny EPS (TTM) wynosi $-0.04. Na koniec roku 2022 firma miała EPS w wysokości $-0.37, wzrost w porównaniu do do EPS z roku 2021, który wynosił $-0.14.
Historia EPS dla Conavi Medical Corp. od 2016 do 2026
EPS na koniec każdego roku
| Rok | EPS | Zmień |
|---|---|---|
| 2026 (TTM) | $-0.04 | -174.83% |
| 2023 | $0.06 | -116.38% |
| 2022 | $-0.37 | 164.29% |
| 2021 | $-0.14 | -63.16% |
| 2020 | $-0.38 | -72.86% |
| 2019 | $-1.40 | 8.53% |
| 2018 | $-1.29 | -70.68% |
| 2017 | $-4.40 | -6.78% |
| 2016 | $-4.72 | 0.00% |
EPS dla podobnych firm lub konkurentów
| Firma | EPS | Różnica w EPS | Kraj |
|---|---|---|---|
| $3.11 | -7,026.50% |
US
|
|
| $3.59 | -8,095.55% |
IE
|
|
| $9.73 | -21,770.38% |
US
|
|
| $2.48 | -5,623.39% |
US
|
|
| - | - |
DE
|
